State Street Corp Cytokinetics Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 6,372,753 shares of CYTK stock, worth $219 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,372,753
Previous 6,085,001
4.73%
Holding current value
$219 Million
Previous $245 Million
13.9%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding CYTK
# of Institutions
368Shares Held
129MCall Options Held
3.62MPut Options Held
1.12M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$604 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$503 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$269 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.65MShares$125 Million4.28% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...